Are Senti Biosciences Inc’shares a good deal?

While Senti Biosciences Inc has overperformed by 775926%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SNTI fell by -39.32%, with highs and lows ranging from $16.94 to $1.52, whereas the simple moving average fell by -37.20% in the last 200 days.

On June 06, 2025, Laidlaw started tracking Senti Biosciences Inc (NASDAQ: SNTI) recommending Buy. A report published by Morgan Stanley on October 07, 2022, Initiated its previous ‘Equal-Weight’ rating for SNTI.

Analysis of Senti Biosciences Inc (SNTI)

Senti Biosciences Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -116.63% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.22, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and SNTI has an average volume of 187.98K. On a monthly basis, the volatility of the stock is set at 8.16%, whereas on a weekly basis, it is put at 12.10%, with a loss of -25.52% over the past seven days. Furthermore, long-term investors anticipate a median target price of $13.50, showing decline from the present price of $187980.0, which can serve as yet another indication of whether SNTI is worth investing in or should be passed over.

How Do You Analyze Senti Biosciences Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 69.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 12.76% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

SNTI shares are owned by institutional investors to the tune of 12.76% at present.

Hot this week

Impact BioMedical Inc (IBO)’s stock chart: A technical perspective

While Impact BioMedical Inc has overperformed by 325711962%, investors...

QMMM Holdings Ltd (QMMM)’s stock performance: a year in review

While QMMM Holdings Ltd has overperformed by 5659645%, investors...

Adial Pharmaceuticals Inc (ADIL)’s stock price in review: A technical analysis

While Adial Pharmaceuticals Inc has overperformed by 1738714%, investors...

A closer look at Novagold Resources Inc (NG)’s stock price trends

While Novagold Resources Inc has overperformed by 1028585%, investors...

TeraWulf Inc (WULF)’s stock rises to 38800000.0 per share

While TeraWulf Inc has overperformed by 20247859%, investors are...

Topics

Impact BioMedical Inc (IBO)’s stock chart: A technical perspective

While Impact BioMedical Inc has overperformed by 325711962%, investors...

QMMM Holdings Ltd (QMMM)’s stock performance: a year in review

While QMMM Holdings Ltd has overperformed by 5659645%, investors...

Adial Pharmaceuticals Inc (ADIL)’s stock price in review: A technical analysis

While Adial Pharmaceuticals Inc has overperformed by 1738714%, investors...

A closer look at Novagold Resources Inc (NG)’s stock price trends

While Novagold Resources Inc has overperformed by 1028585%, investors...

TeraWulf Inc (WULF)’s stock rises to 38800000.0 per share

While TeraWulf Inc has overperformed by 20247859%, investors are...

Banzai International Inc (BNZI) stock analysis: A comprehensive overview

While Banzai International Inc has overperformed by 1332362%, investors...

Capricor Therapeutics Inc (CAPR)’s stock price range in the last year

While Capricor Therapeutics Inc has overperformed by 2946575%, investors...

Office Properties Income Trust (OPI) stock: A year of ups and downs

While Office Properties Income Trust has overperformed by 1375615%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.